Clinical Trial

Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis Patients

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated June 12, 2023 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what research attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of pulmonary fibrosis patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future pulmonary fibrosis patients.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT05899556
Lead Sponsor Power Life Sciences Inc.
Conditions Pulmonary Fibrosis
Enrollment 500 participants
Start Date 2024-07
Primary Completion 2025-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2023-06-12